Compare Incyte Corporation (INCY) vs Qurate Retail Inc Series A (QVCAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Incyte Corporation vs Qurate Retail Inc Series A — how do they compare? Incyte Corporation trades at $115.7 (market cap $23.11B), while Qurate Retail Inc Series A trades at $0.05 (market cap $698.27K). The key difference: Incyte Corporation is far larger — about 33096.1× Qurate Retail Inc Series A's market cap, and Incyte Corporation is trading nearer its 52-week high, Qurate Retail Inc Series A nearer its low. Which is the better fit depends on your goals.
| INCY | QVCAQ | |
|---|---|---|
Market Cap | $23.11B | $698.27K |
Sector | Health | Consumer Cyclical |
52-Week High | $118.52 | $15.03 |
52-Week Low | $67.38 | $0.05 |
Enterprise Value | $19.13B | $4.73B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Incyte Corporation
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Read more on INCY →About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →
